Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

2.

PPARγ Is Activated during Congenital Cytomegalovirus Infection and Inhibits Neuronogenesis from Human Neural Stem Cells.

Rolland M, Li X, Sellier Y, Martin H, Perez-Berezo T, Rauwel B, Benchoua A, Bessières B, Aziza J, Cenac N, Luo M, Casper C, Peschanski M, Gonzalez-Dunia D, Leruez-Ville M, Davrinche C, Chavanas S.

PLoS Pathog. 2016 Apr 14;12(4):e1005547. doi: 10.1371/journal.ppat.1005547. eCollection 2016 Apr.

3.

Cytomegalovirus Infection Triggers the Secretion of the PPARγ Agonists 15-Hydroxyeicosatetraenoic Acid (15-HETE) and 13-Hydroxyoctadecadienoic Acid (13-HODE) in Human Cytotrophoblasts and Placental Cultures.

Leghmar K, Cenac N, Rolland M, Martin H, Rauwel B, Bertrand-Michel J, Le Faouder P, Bénard M, Casper C, Davrinche C, Fournier T, Chavanas S.

PLoS One. 2015 Jul 14;10(7):e0132627. doi: 10.1371/journal.pone.0132627. eCollection 2015.

4.

Human Cytomegalovirus Infection Dysregulates the Localization and Stability of NICD1 and Jag1 in Neural Progenitor Cells.

Li XJ, Liu XJ, Yang B, Fu YR, Zhao F, Shen ZZ, Miao LF, Rayner S, Chavanas S, Zhu H, Britt WJ, Tang Q, McVoy MA, Luo MH.

J Virol. 2015 Jul;89(13):6792-804. doi: 10.1128/JVI.00351-15. Epub 2015 Apr 22.

5.

MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a.

Fu YR, Liu XJ, Li XJ, Shen ZZ, Yang B, Wu CC, Li JF, Miao LF, Ye HQ, Qiao GH, Rayner S, Chavanas S, Davrinche C, Britt WJ, Tang Q, McVoy M, Mocarski E, Luo MH.

J Virol. 2015 Jan 15;89(2):1070-82. doi: 10.1128/JVI.01740-14. Epub 2014 Nov 5.

6.

Comprehensive analysis of human cytomegalovirus microRNA expression during lytic and quiescent infection.

Shen ZZ, Pan X, Miao LF, Ye HQ, Chavanas S, Davrinche C, McVoy M, Luo MH.

PLoS One. 2014 Feb 12;9(2):e88531. doi: 10.1371/journal.pone.0088531. eCollection 2014.

7.

A new amyloidosis caused by fibrillar aggregates of mutated corneodesmosin.

Caubet C, Bousset L, Clemmensen O, Sourigues Y, Bygum A, Chavanas S, Coudane F, Hsu CY, Betz RC, Melki R, Simon M, Serre G.

FASEB J. 2010 Sep;24(9):3416-26. doi: 10.1096/fj.10-155622. Epub 2010 May 6.

PMID:
20448140
8.

Transcriptional regulation of peptidylarginine deiminase expression in human keratinocytes.

Ying S, Dong S, Kawada A, Kojima T, Chavanas S, Méchin MC, Adoue V, Serre G, Simon M, Takahara H.

J Dermatol Sci. 2009 Jan;53(1):2-9. doi: 10.1016/j.jdermsci.2008.09.009. Epub 2008 Nov 11. Review.

PMID:
19004619
9.

Long-range enhancer differentially regulated by c-Jun and JunD controls peptidylarginine deiminase-3 gene in keratinocytes.

Adoue V, Chavanas S, Coudane F, Méchin MC, Caubet C, Ying S, Dong S, Duplan H, Charveron M, Takahara H, Serre G, Simon M.

J Mol Biol. 2008 Dec 31;384(5):1048-57. doi: 10.1016/j.jmb.2008.10.019. Epub 2008 Oct 15.

PMID:
18952102
10.

Long-range enhancer associated with chromatin looping allows AP-1 regulation of the peptidylarginine deiminase 3 gene in differentiated keratinocyte.

Chavanas S, Adoue V, Méchin MC, Ying S, Dong S, Duplan H, Charveron M, Takahara H, Serre G, Simon M.

PLoS One. 2008;3(10):e3408. doi: 10.1371/journal.pone.0003408. Epub 2008 Oct 16.

11.

Update on peptidylarginine deiminases and deimination in skin physiology and severe human diseases.

Méchin MC, Sebbag M, Arnaud J, Nachat R, Foulquier C, Adoue V, Coudane F, Duplan H, Schmitt AM, Chavanas S, Guerrin M, Serre G, Simon M.

Int J Cosmet Sci. 2007 Jun;29(3):147-68. doi: 10.1111/j.1467-2494.2007.00377.x.

12.

Crucial roles of MZF1 and Sp1 in the transcriptional regulation of the peptidylarginine deiminase type I gene (PADI1) in human keratinocytes.

Dong S, Ying S, Kojima T, Shiraiwa M, Kawada A, Méchin MC, Adoue V, Chavanas S, Serre G, Simon M, Takahara H.

J Invest Dermatol. 2008 Mar;128(3):549-57. Epub 2007 Sep 13.

13.

Peptidylarginine deiminases and deimination in biology and pathology: relevance to skin homeostasis.

Chavanas S, Méchin MC, Nachat R, Adoue V, Coudane F, Serre G, Simon M.

J Dermatol Sci. 2006 Nov;44(2):63-72. Epub 2006 Sep 14. Review.

PMID:
16973334
14.

NF-Y and Sp1/Sp3 are involved in the transcriptional regulation of the peptidylarginine deiminase type III gene (PADI3) in human keratinocytes.

Dong S, Kanno T, Yamaki A, Kojima T, Shiraiwa M, Kawada A, Méchin MC, Chavanas S, Serre G, Simon M, Takahara H.

Biochem J. 2006 Aug 1;397(3):449-59.

15.

The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locations.

Méchin MC, Enji M, Nachat R, Chavanas S, Charveron M, Ishida-Yamamoto A, Serre G, Takahara H, Simon M.

Cell Mol Life Sci. 2005 Sep;62(17):1984-95.

PMID:
16091842
16.

Regulation of the expression of peptidylarginine deiminase type II gene (PADI2) in human keratinocytes involves Sp1 and Sp3 transcription factors.

Dong S, Kojima T, Shiraiwa M, Méchin MC, Chavanas S, Serre G, Simon M, Kawada A, Takahara H.

J Invest Dermatol. 2005 May;124(5):1026-33.

17.

Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin.

Nachat R, Méchin MC, Takahara H, Chavanas S, Charveron M, Serre G, Simon M.

J Invest Dermatol. 2005 Feb;124(2):384-93.

18.

Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6.

Chavanas S, Méchin MC, Takahara H, Kawada A, Nachat R, Serre G, Simon M.

Gene. 2004 Apr 14;330:19-27.

PMID:
15087120
19.

Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families.

Bitoun E, Chavanas S, Irvine AD, Lonie L, Bodemer C, Paradisi M, Hamel-Teillac D, Ansai S, Mitsuhashi Y, Taïeb A, de Prost Y, Zambruno G, Harper JI, Hovnanian A.

J Invest Dermatol. 2002 Feb;118(2):352-61.

20.

Gene polymorphism in Netherton and common atopic disease.

Walley AJ, Chavanas S, Moffatt MF, Esnouf RM, Ubhi B, Lawrence R, Wong K, Abecasis GR, Jones EY, Harper JI, Hovnanian A, Cookson WO.

Nat Genet. 2001 Oct;29(2):175-8.

PMID:
11544479
21.

The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis.

Sprecher E, Chavanas S, DiGiovanna JJ, Amin S, Nielsen K, Prendiville JS, Silverman R, Esterly NB, Spraker MK, Guelig E, de Luna ML, Williams ML, Buehler B, Siegfried EC, Van Maldergem L, Pfendner E, Bale SJ, Uitto J, Hovnanian A, Richard G.

J Invest Dermatol. 2001 Aug;117(2):179-87.

22.

Reduced expression of the epithelial adhesion ligand laminin 5 in the skin causes intradermal tissue separation.

Spirito F, Chavanas S, Prost-Squarcioni C, Pulkkinen L, Fraitag S, Bodemer C, Ortonne JP, Meneguzzi G.

J Biol Chem. 2001 Jun 1;276(22):18828-35. Epub 2001 Mar 14.

23.

Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome.

Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafé JL, Wilkinson J, Taïeb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A.

Nat Genet. 2000 Jun;25(2):141-2.

PMID:
10835624
24.

Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping.

Chavanas S, Garner C, Bodemer C, Ali M, Teillac DH, Wilkinson J, Bonafé JL, Paradisi M, Kelsell DP, Ansai Si, Mitsuhashi Y, Larrègue M, Leigh IM, Harper JI, Taïeb A, Prost Yd, Cardon LR, Hovnanian A.

Am J Hum Genet. 2000 Mar;66(3):914-21.

25.

Splicing modulation of integrin beta4 pre-mRNA carrying a branch point mutation underlies epidermolysis bullosa with pyloric atresia undergoing spontaneous amelioration with ageing.

Chavanas S, Gache Y, Vailly J, Kanitakis J, Pulkkinen L, Uitto J, Ortonne J, Meneguzzi G.

Hum Mol Genet. 1999 Oct;8(11):2097-105.

PMID:
10484780
26.

Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion--reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes.

Borradori L, Chavanas S, Schaapveld RQ, Gagnoux-Palacios L, Calafat J, Meneguzzi G, Sonnenberg A.

Exp Cell Res. 1998 Mar 15;239(2):463-76.

PMID:
9521865
27.

A homozygous in-frame deletion in the collagenous domain of bullous pemphigoid antigen BP180 (type XVII collagen) causes generalized atrophic benign epidermolysis bullosa.

Chavanas S, Gache Y, Tadini G, Pulkkinen L, Uitto J, Ortonne JP, Meneguzzi G.

J Invest Dermatol. 1997 Jul;109(1):74-8. Erratum in: J Invest Dermatol 1997 Oct;109(4):613.

28.

A homozygous nonsense mutation in the PLEC1 gene in patients with epidermolysis bullosa simplex with muscular dystrophy.

Chavanas S, Pulkkinen L, Gache Y, Smith FJ, McLean WH, Uitto J, Ortonne JP, Meneguzzi G.

J Clin Invest. 1996 Nov 15;98(10):2196-200.

29.

Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy.

Gache Y, Chavanas S, Lacour JP, Wiche G, Owaribe K, Meneguzzi G, Ortonne JP.

J Clin Invest. 1996 May 15;97(10):2289-98.

Supplemental Content

Loading ...
Support Center